Kukje Pharma Co., Ltd. (KRX: 002720)

Kukje Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,583	10,590	5,539	7,866	4,013	7,448
Short-Term Investments	-	-	-	-	-	2,500
Trading Asset Securities	15.62	42.29	20.18	36.91	260.42	124.01
Cash & Short-Term Investments	8,598	10,632	5,559	7,903	4,273	10,072
Cash Growth	-15.52%	91.26%	-29.66%	84.93%	-57.57%	46.71%
Accounts Receivable	19,154	20,429	19,131	20,653	20,251	20,667
Other Receivables	1,766	708.07	1,222	2,819	3,654	13,168
Receivables	21,924	22,141	20,359	23,486	23,937	34,146
Inventory	21,810	21,243	22,235	16,540	21,652	16,595
Prepaid Expenses	42.18	35.34	35.21	23.51	27.9	19.49
Other Current Assets	958.87	1,067	347.29	244.12	49.84	302.44
Total Current Assets	53,333	55,119	48,535	48,197	49,940	61,135
Property, Plant & Equipment	98,484	99,124	78,380	81,981	86,986	64,888
Long-Term Investments	4,851	3,195	3,984	3,953	2,855	2,016
Other Intangible Assets	905.64	919.29	944.49	935.19	877.02	845.13
Long-Term Deferred Charges	-	0	180.95	398.08	615.22	832.35
Other Long-Term Assets	4,843	4,902	4,569	4,319	4,352	4,877
Total Assets	162,416	163,259	136,593	139,783	145,626	134,594
Accounts Payable	7,900	8,564	7,068	7,249	7,248	8,608
Accrued Expenses	873.96	918.01	1,235	1,110	1,110	1,108
Short-Term Debt	2,000	30,000	27,000	32,000	32,000	33,059
Current Portion of Long-Term Debt	-	-	-	2,000	2,000	-
Current Portion of Leases	174.67	186.34	399.95	366.36	343.72	279.4
Current Income Taxes Payable	1,399	1,566	1,488	302.48	2,489	3,682
Other Current Liabilities	11,225	18,453	10,664	11,489	10,166	12,515
Total Current Liabilities	23,572	59,687	47,855	54,517	55,358	59,251
Long-Term Debt	27,000	-	-	-	2,000	2,000
Long-Term Leases	380.72	475.74	1,196	1,620	1,792	256.39
Long-Term Deferred Tax Liabilities	12,763	13,054	7,895	7,248	7,201	3,510
Other Long-Term Liabilities	6,014	5,092	4,323	2,538	2,165	2,152
Total Liabilities	72,542	78,310	62,514	71,195	75,127	73,640
Common Stock	21,160	21,160	20,195	19,276	18,401	18,401
Additional Paid-In Capital	-2,639	2,094	3,059	3,978	4,854	4,854
Retained Earnings	5,697	-3,391	6,327	1,095	3,059	492.98
Treasury Stock	-1,987	-2,566	-2,535	-2,494	-2,449	-2,449
Comprehensive Income & Other	67,626	67,647	47,028	46,714	46,618	39,631
Total Common Equity	89,857	84,944	74,074	68,568	70,482	60,929
Minority Interest	16.95	5.49	5.19	19.75	16.41	24.84
Shareholders' Equity	89,874	84,950	74,079	68,588	70,499	60,954
Total Liabilities & Equity	162,416	163,259	136,593	139,783	145,626	134,594
Total Debt	29,555	30,662	28,596	35,987	38,136	35,595
Net Cash (Debt)	-20,957	-20,030	-23,037	-28,084	-33,862	-25,523
Net Cash Per Share	-1030.66	-988.96	-1137.06	-1385.71	-1670.44	-1258.98
Filing Date Shares Outstanding	20.36	20.25	20.26	20.27	19.31	20.27
Total Common Shares Outstanding	20.36	20.25	20.26	20.27	20.27	20.27
Working Capital	29,761	-4,568	680.31	-6,319	-5,417	1,884
Book Value Per Share	4412.86	4194.43	3656.47	3383.53	3476.90	3005.63
Tangible Book Value	88,951	84,025	73,130	67,633	69,605	60,084
Tangible Book Value Per Share	4368.38	4149.04	3609.85	3337.38	3433.63	2963.94
Land	-	72,736	46,629	46,808	46,808	35,543
Buildings	-	25,563	26,478	26,804	26,804	25,597
Machinery	-	39,015	40,488	41,862	41,326	33,076
Construction In Progress	-	91.5	123	151.85	2,771	3,977

Source: S&P Capital IQ. Standard template. Financial Sources.